Literature DB >> 20887702

Ablative laser resurfacing: is it still the gold standard for facial rejuvenation?

Daška Stulhofer Buzina1, Jasna Lipozenčić, Zrinka Bukvić Mokos, Romana Ceović, Krešimir Kostović.   

Abstract

A new era in dermatological cosmetology, especially in the field of nonsurgical skin rejuvenation, started with ablative resurfacing, at first by carbon dioxide laser and later by Er:YAG or their combination. Although ablative lasers result in major improvements in photodamaged skin, the related postoperative recovery time and side effects are currently unacceptable for most patients. During the last forty years, skin resurfacing has changed dramatically. After ablative laser systems, nonablative and now fractional laser systems have been developed, fulfilling the new demands for a lesser risk of side effects and minimal or no downtime.

Entities:  

Mesh:

Year:  2010        PMID: 20887702

Source DB:  PubMed          Journal:  Acta Dermatovenerol Croat        ISSN: 1330-027X            Impact factor:   1.256


  4 in total

1.  The effect of conditioned media of adipose-derived stem cells on wound healing after ablative fractional carbon dioxide laser resurfacing.

Authors:  Bing-Rong Zhou; Yang Xu; Shi-Lei Guo; Yan Xu; Ying Wang; Fen Zhu; Felicia Permatasari; Di Wu; Zhi-Qiang Yin; Dan Luo
Journal:  Biomed Res Int       Date:  2013-12-04       Impact factor: 3.411

2.  Skin renewal activity of non-thermal plasma through the activation of β-catenin in keratinocytes.

Authors:  J H Choi; Y S Song; K Song; H J Lee; J W Hong; G C Kim
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

Review 3.  Skin resurfacing procedures: new and emerging options.

Authors:  Mathew M Loesch; Ally-Khan Somani; Melanie M Kingsley; Jeffrey B Travers; Dan F Spandau
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-08-28

4.  The Efficacy and Safety of Fractional CO₂ Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study.

Authors:  Jie Zhu; Xi Ji; Min Li; Xiao-e Chen; Juan Liu; Jia-an Zhang; Dan Luo; Bing-rong Zhou
Journal:  Biomed Res Int       Date:  2016-02-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.